In November 2020, Jincheng pharma, a listed enterprise, easily disclosed two Synthetic Nicotine technology patents through interaction. With the tightening of e-cigarette regulatory policies and Synthetic Nicotine technology, many e-cigarette brands have made an early layout to deal with possible nicotine regulation.

Two nicotine patents disclosed by Jincheng pharma, one of which has carried out in-depth cooperation with Hangsen Yongji Technology (Shenzhen) Co., Ltd. (hereinafter referred to as Hangsen Technology) as a patent co applicant; Another patent is applied for by Jincheng pharma itself.

“At present, Synthetic Nicotine can be used in both e-cigarettes and medicine, but the requirements for the purity of Synthetic Nicotine in these two fields are different. Generally, the purity of Synthetic Nicotine used in e-cigarettes should reach 99.5%. At present, our samples are enough to meet the requirements. Our nicotine is chemically synthesized and can reach 99.6% after being made, so for electronic cigarettes Cigarette is more than enough, which has been verified by downstream customers. There is no problem at all. Moreover, the demand for e-cigarettes in the market is very large, and the supply is less than the demand. Therefore, after the launch of nicotine products, our first step is to supply e-cigarettes, which will bring sales revenue. On the other hand, nicotine can also be used for medicine, but the price of medical nicotine is relatively low At the same time, it also requires higher purity, which needs to reach 99.9%. The nicotine extracted by our current process is not far from this purity standard. The company will first meet the needs of e-cigarettes, improve the technical process, and then slowly enter the pharmaceutical field. After the nicotine project passes the safety assessment and environmental assessment, it will enter the civil construction procedure immediately, which is expected to be in the second half of next year It can only be put into operation in, and the company will pay close attention to improving the speed. ”

Synthetic Nicotine is one of the latest technical research directions of Zhongxiang. On the one hand, it seeks new growth points and markets. On the other hand, with the increasingly strict regulation of national laws and regulations, especially for tobacco products, the use of natural nicotine in e-cigarettes is becoming more and more limited, while Synthetic Nicotine does not involve tobacco products, so there are no similar restrictions for the time being. If Synthetic Nicotine does become the standard to distinguish e-cigarettes from traditional tobacco industry, it will be a great thing. Although policy changes are beyond our control, there are several things we can do: constantly optimize the production process of Synthetic Nicotine, improve the production capacity of mass production while ensuring quality, and constantly develop new technologies to reduce production costs. If we put aside the impact of policies, Synthetic Nicotine can also be popularized, which will be a revolutionary step, and we can see the potential behind it. ”

We specialize in manufacturing chemical Synthetic Nicotine ( CAS No.: 54-11-5 ) in China. we have the highest technology and stable quality control , our factory has sophisticated technology production route to produce the above products ,welcome to inquiry it .Please contact us by e-mail nicotine@haihengpharma.com for quotation requests. Please provide quantity, purity, and any other specific requirements.

Synthetic NicotineSynthetic Nicotine is used for Medical and Drug
In November 2020, Jincheng pharma, a listed enterprise, easily disclosed two Synthetic Nicotine technology patents through interaction. With the tightening of e-cigarette regulatory policies and Synthetic Nicotine technology, many e-cigarette brands have made an early layout to deal with possible nicotine regulation. Two nicotine patents disclosed by Jincheng pharma, one...